HomeNewsBusinessStartupIt is back to work-from-home for startups as India stares at third wave of pandemic 

It is back to work-from-home for startups as India stares at third wave of pandemic 

Stay away from office

January 05, 2022 / 13:52 IST
Story continues below Advertisement
Representative image
Representative image

With the number of Covid-19 cases surging in India because of the highly transmissible Omicron variant, some of the country’s biggest internet companies and startups are taking no chances.

Over half a dozen companies Moneycontrol spoke to said they have moved to the work from home (WFH) model fully again, with no plans to return to office in the foreseeable future. They’ve also stepped up testing for employees and announced special leaves and incentives for those who have tested positive for Covid-19, and put business travel on the back burner.

Story continues below Advertisement

WFH IS BACK 

India’s leading e-commerce platform Flipkart has advised its employees to not come to the office for the next two weeks or until further notice. It has also been organising vaccination camps at its facilities across the country for its supply chain employees, apart from organising sessions to cover key aspects of vaccination and address concerns around Covid-19.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show